Videos

Featured

Optimisation of Guideline-directed Medical Therapy in Cardiorenal Patients

Ileana L Piña, David Wheeler, , et al

Watch time: 45m 39s
Importance of Testing for CKD Among Patients With Type 2 Diabetes

Pam Taub, Nikolaus Marx

Watch time: 10m 51s

Harold Bays, Lydia Alexander, Liesbeth van Rossum, et al

ESC 24 Hot Line Discussion: The FINEARTS-HF Trial

Harriette Van Spall, Scott Solomon

Watch time: 17m 28s

Andrew Frankel, Shelley Zieroth et al

Vijay Chopra, Deepak L Bhatt, George L Bakris, et al

Weight Loss Medications: What You Need to Know in 2024

Harold Bays

Watch time: 6m 21s
Glucagon-Containing Dual and Triple Agonists For Obesity and MASH

Scott Harris

Watch time: 8m 36s

Trending

Thomas Weber, Bryan Williams et al

Harriette Van Spall, Mikhail Kosiborod

Watch time: 22m 30s (11 videos)

Anjay Rastogi

Andrew JS Coats, Stefan Anker

AHA 24 Late-Breaking Discussion: The SUMMIT Trial

Harriette Van Spall, Milton Packer

Watch time: 17m 22s

Thomas Weber, Erika SW Jones, Bryan Williams et al

Harold Bays, Lydia Alexander, Liesbeth van Rossum, et al

HFA 24: FINE-HEART: Design & Baseline Characteristics

Muthiah Vaduganathan

Watch time: 4m 40s
AHA 24 Late-Breaking Discussion: The FLOW Trial

Harriette Van Spall,

Watch time: 16m 57s

Fausto J Pinto, John Spertus et al

Events

Filter by

AHA 24 Late-Breaking Discussion: The SUMMIT Trial

Harriette Van Spall, Milton Packer

Watch time: 17m 22s
AHA 24 Late-Breaking Discussion: The FLOW Trial

Harriette Van Spall,

Watch time: 16m 57s
HFSA 24: STEP-HFpEF: Exercise Function and Frailty Status

Mikhail Kosiborod

Watch time: 12m 9s
HFSA 24: The HuMAIN-HFpEF Trial

Ambarish Pandey

Watch time: 4m 5s
EASD 24: FINEARTS-HF: Diabetes Status Analysis

John JV McMurray

Watch time: 14m 10s
FLOW: Kidney, Cardiovascular, Mortality, Metabolic and Safety Results

Richard Pratley

Watch time: 6m 39s
EASD 24: Effectiveness of Empagliflozin and GLP1s

Phyo Htoo

Watch time: 5m 24s
ESC 24 Hot Line Discussion: The FINEARTS-HF Trial

Harriette Van Spall, Scott Solomon

Watch time: 17m 28s
ESC 24: FINE-HEART: Finerenone in HF & CKD

Muthiah Vaduganathan

Watch time: 4m 24s
ESC 24: MRAs in Heart Failure

Watch time: 5m 46s

Latest

Filter by

HFA 24: Timing of Cardio-Kidney Protection with SGLT2i

Muthiah Vaduganathan

Watch time: 5m 24s

Andrew Frankel, Shelley Zieroth et al

IMPACT CKD: 10-year Outlook on CKD

Jerome Rossert

Watch time: 5m 22s
ACC.24: The STEP HFpEF DM Trial

Mikhail Kosiborod

Watch time: 6m 41s
Weight Loss Medications: What You Need to Know in 2024

Harold Bays

Watch time: 6m 21s
ACC 24 Late-Breaker Discussion: The EMPACT-MI Trial

Harriette Van Spall, Javed Butler

Watch time: 22m 43s
Optimisation of Guideline-directed Medical Therapy in Cardiorenal Patients

Ileana L Piña, David Wheeler, , et al

Watch time: 45m 39s
SGLT2i: Best Practices in Implementation Across HF, Diabetes and CKD

Clara Saldarriaga, Shelley Zieroth, , et al

Watch time: 37m 3s